All In MedTech

FDA Clearance Tracker · P110016-S080

FlexAbility™ Ablation Catheter, Sensor Enabled™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 14, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 14, 2022

Approved

Time to decision

247 days

Received Apr 11, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P110016-S080
Device name
FlexAbility™ Ablation Catheter, Sensor Enabled™
Applicant location
Plymouth, MN
Received
Apr 11, 2022
Decided
Dec 14, 2022
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P110016

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

Approval for expanding the indications to include the treatment of ventricular tachycardia to the current approved device indication for use.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.